Yes, session recordings are available for purchase as an optional add-on to your participation, allowing you to access all content after the event at your convenience.
Contamination Control in Sterile Manufacturing: Bridging the Gap Between Annex 1 Expectations and Reality
Transforming Contamination Control from a Compliance Activity into Operational Excellence
This 4-session webinar provides a comprehensive, practitioner-led exploration of contamination control in sterile and aseptic pharmaceutical manufacturing. The programme spans environmental monitoring design, contamination control strategy development, excursion investigation, aseptic behaviour, and regulatory inspection readiness under EU GMP Annex 1 (2023). Each session is designed to stand alone but together forms a complete learning journey — from foundational monitoring principles through to inspection-ready quality system documentation.
Contamination control in sterile manufacturing has undergone a fundamental shift in regulatory expectation. EU GMP Annex 1 (2023 revision) requires manufacturers to demonstrate not just that monitoring programmes are in place, but that they are embedded in a living, risk-based Contamination Control Strategy that drives operational decisions and quality culture.
Speakers
Key points
How to design and validate an environmental monitoring programme that meets EU GMP Annex 1 requirements and withstands regulatory scrutiny
The principles of trending and alert/action limit setting for microbial and particulate data, including statistical approaches and risk-based justifications
How contamination control strategy documents are structured, maintained, and used as living tools rather than compliance artefacts
Practical approaches to root cause investigation following environmental excursions, including the role of microbiological identification
Aseptic behaviour and human factors: how personnel practices remain the leading source of contamination risk and what training interventions are effective
Isolator and RABS technology considerations: how barrier design choices affect monitoring strategy and contamination risk profile
How to translate monitoring data into site-level quality decisions, including escalation frameworks and CAPA management
Preparing for and responding to regulatory observations on contamination control, including FDA 483 and EMA deficiencies
Who should attend
Chief Executives, Vice Presidents, Directors, Heads, Leaders, and Managers specializing in:
- Quality Assurance Managers & Contamination Control Specialists
- Regulatory Affairs Professionals
- Microbiologists & Environmental Monitoring Scientists
- Aseptic Processing & Fill-Finish Operations Teams
- Validation & Qualification Specialists
- Senior Leaders & Heads of Quality / Manufacturing
Contamination Control in Sterile Manufacturing: Bridging the Gap Between Annex 1 Expectations and Reality
Transforming Contamination Control from a Compliance Activity into Operational Excellence
Past events
FAQ
Your questions answered here.
The webinar is streamed exclusively through the Cvent platform. Registered attendees will receive a secure link to join.
Yes. All in One & Standard packages include attendance provide a digital certificate.
All summit sessions will be presented in English. While translation services are not provided, we welcome attendees from around the world and encourage everyone to join the discussions and networking opportunities.
We’d love to help you make the most of the summit! You can request the summit brochure or contact our team directly using the details below. Our team is happy to answer any questions and guide you in planning your participation.
For any event assistance please contact
Stay informed. Stay ahead
Subscribe to our newsletter for exclusive pharma event updates, industry insights, and speaker announcements.